Beilu Pharmaceutical: Obtained the Drug Registration Certificate for Sildenafil Citrate Orally Disintegrating Tablets.

Northland Pharmaceutical Industry Announcement: Recently, the company received the "Drug Registration Certificate" for the citric acid sildenafil orally disintegrating tablets approved and issued by the National Medical Products Administration. Sildenafil is a type 5 phosphodiesterase selective inhibitor used to treat erectile dysfunction, with advantages such as rapid onset and definite efficacy. The citric acid sildenafil orally disintegrating tablets are an iterated formulation of sildenafil developed by Pfizer, approved for import in China in 2019. These tablets do not require patients to drink water, can disintegrate in the mouth within seconds, have a fast onset time, and can meet the needs of patients looking for convenient, fast-acting, and discreet oral medications, providing patients with a more flexible and diverse choice for medication.